The Cancer Detective: Liquid Biopsies and the Quest for Early Detection The medical world is abuzz with the potential of liquid biopsies, a relatively new approach to cancer detection that uses simple blood tests to spot tiny fragments of tumour DNA.
This technology has far reaching implications, particularly in identifying residual disease in cancer survivors. Paul Lonergan's case is a prime example.
The 63 year old Toronto resident was diagnosed with a large tumour at the base of his tongue after months of visits to doctors.